Tradr 2X Long Innovation 100 Monthly ETF

MQQQ provides 2x leveraged exposure to the monthly performance of QQQ, an ETF composed of 100 NASADAQ-listed stocks. The strategy involves entering into one or more swap agreements intended to produce leveraged investment results relative to the returns of QQQ. Unlike traditional ETFs, MQQQ introduces added volatility due to its lack of diversification and use of leverage. Holdings are rebalanced at month-end to maintain the 200% exposure. However, if QQQs price drops by 35% or more within a month, the fund will rebalance early to protect against further losses, although this may prevent it from meeting its target return for that month. To maximize results, the fund places its remaining cash in US government securities, money market funds, short-term bond ETFs, or high-quality corporate debt as collateral. Before May 16, 2025, the fund was named Tradr 2X Long Triple Q Monthly ETF.

Tradr 2X Long Innovation 100 Monthly ETF trades as MQQQ on NASDAQ. The company is classified in Financial Services / Asset Management - Leveraged and reports in USD.

The current profile places the business in Asset Management - Leveraged. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Tradr 2X Long Innovation 100 Monthly ETF can be compared against peers such as Roundhill Investments - AMZN WeeklyPay ETF, Calamos S&P 500 Structured Alt Protection ETF – February, GraniteShares 2x Long MSFT Daily ETF, T-REX 2X Inverse NVIDIA Daily Target ETF, Innovator Growth Accelerated Plus ETF, Innovator Growth Accelerated Plus ETF.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $26.59M, beta of 2.66, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

MQQQ currently shows total debt of N/A and beta of 2.66. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.tradretfs.com/mqqq-2x-long-triple-q-monthly-etf

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.